Bath & Body Works
BBWI
17.81
-0.12
-0.67%
Bath & Body Works
US · BBWI
#2384 by market cap
Listed 1970
17.81
-0.12
-0.67%
Live - 5344 symbols - heartbeat 262s ago
· 2026-10-07 19:54
After-hours
17.81
0.00%
- Market cap
- 3.59B
- P/E (TTM)i
- 4.67
- P/Bi
- -3.40
- EPSi
- 3.11
- Div yieldi
- 4.49%
- 52W posi
- 32%
Reader sentiment
Are you bullish or bearish on BBWI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 104.26% +0.20pp
- Institutions
- 547 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund72.81%
Hedge Fund20.74%
Public Company4.41%
Government Pension Fund3.86%
Sovereign Wealth Fund1.22%
Private Company0.76%
Individual/Insider0.36%
Family Office/Trust0.20%
Top holders as of 2026-06-30
FMR
10.08% · 20.33M sh
BlackRock
9.63% · 19.41M sh
Vanguard Portfolio Management, LLC
8.44% · 17.02M sh
Vanguard Capital Management, LLC
5.13% · 10.34M sh
D. E. Shaw & Co., L.P.
3.83% · 7.73M sh
AQR Capital Management
3.77% · 7.59M sh
State Street Global Advisors
3.54% · 7.14M sh
AllianceBernstein
2.78% · 5.61M sh
Citadel Advisors LLC
2.53% · 5.11M sh
American Century Investment Management
2.03% · 4.09M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 36 buys · 9 sells
| Name | Role | Stake |
|---|---|---|
| Sarah Nash | Independent Chairperson | 0.15% |
| Stephen Steinour | Independent Director | 0.04% |
| Thomas Mazurek | Chief Supply Chain Officer | 0.04% |
| Michael Wu | Chief Legal Officer | 0.03% |
| James Symancyk | Independent Director | 0.02% |
| Eva Boratto | Chief Financial Officer | 0.02% |
| Steven Voskuil | Independent Director | 0.02% |
| Francis Hondal | Independent Director | 0.01% |
| Danielle Lee | Independent Director | 0.01% |
| Lucy Brady | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-20 | Daniel Heaf | Chief Executive Officer | Other Derivative Acquisition | +591,366 | -- |
| 2026-08-09 | Ann Aber | Chief Legal Officer | Other Acquisition | +12,940 | -- |
| 2026-06-11 | Tom Javitch | Interim Chief Financial Officer | Other Acquisition | +10,309 | -- |
| 2026-06-11 | Tom Javitch | Interim Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-11 | David Meeting | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-10 | Stephen Steinour | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Alessandro Bogliolo | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Sarah Nash | Independent Chairperson | Other Acquisition | +13,284 | -- |
| 2026-06-10 | Francis Hondal | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Veronique Gabai-Pinsky | Chief Brand & Product Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-10 | Steven Voskuil | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Juan Rajlin | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | James Symancyk | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Lucy Brady | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Danielle Lee | Independent Director | Other Acquisition | +7,970 | -- |
| 2026-06-10 | Maly Bernstein | Chief Commercial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-05-18 | Thomas Mazurek | Chief Supply Chain Officer | Sale to Issuer | -4,127 | $16.11 |
| 2026-05-18 | Thomas Mazurek | Chief Supply Chain Officer | Other Acquisition | +6,616 | -- |
| 2026-05-15 | Daniel Heaf | Chief Executive Officer | Sale to Issuer | -7,334 | $17.09 |
| 2026-03-12 | Eva Boratto | Chief Financial Officer | Sale to Issuer | -10,782 | $19.50 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.